{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:10:16Z","timestamp":1792253416774,"version":"4.4.0"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi250845-4\"><jats:title>Importance<\/jats:title><jats:p>Trisomy 13 (T13) and trisomy 18 (T18) are chromosomal abnormalities with high mortality rates in the first year of life. Understanding differences in long-term survival between children with full vs mosaic or partial trisomy is crucial for prognosis and health care planning.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250845-5\"><jats:title>Objective<\/jats:title><jats:p>To examine the differences in 10-year survival between children with full T13 and T18 vs those with mosaic or partial trisomy.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250845-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This retrospective, population-based cohort study assessed liveborn infants with T13 and T18 in the Texas Birth Defects Registry (deliveries from January 1, 1999, to December 31, 2008). Follow-up was through December 31, 2018 (the last date available at the time of analyses) to allow for 10 years of follow-up for all infants. All analyses were conducted from January 1, 2022, to December 31, 2024.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250845-7\"><jats:title>Exposures<\/jats:title><jats:p>Cytogenetic status (full trisomy vs mosaic or partial trisomy).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250845-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The primary outcome was survival to 10 years of age, assessed using Kaplan-Meier survival estimates. The association between cytogenetic status and mortality by 10 years of age was assessed using Cox proportional hazards regression to generate hazard ratios (HRs). Population attributable fraction was calculated to determine the percentage of survival attributable to mosaic or partial trisomy status.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250845-9\"><jats:title>Results<\/jats:title><jats:p>The study cohort included 798 infants (463 female infants [58.0%]; mean [SD] maternal age, 30.9 [8.0] years) with T13 (n\u2009=\u2009295) or T18 (n\u2009=\u2009503). Among all cases with T13, 25 infants (8.5%; 95% CI, 5.5%-12.3%) survived to 10 years of age. Similarly, among all infants with T18, 43 (8.6%; 95% CI, 6.3%-11.3%) survived to 10 years of age. Kaplan-Meier survival estimates to 10 years of age were statistically significantly higher among children with mosaic or partial trisomy (13 [25.0%] and 14 [43.8%], respectively) compared with full trisomy (12 [4.9%] and 29 [6.6%], respectively) (both <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001). Infants with full trisomy had statistically significantly increased 10-year mortality hazards compared with those with mosaic or partial trisomy for both T13 (HR, 2.00; 95% CI, 1.42-2.82) and T18 (HR, 3.34; 95% CI, 2.08-5.38). The results of the calculated proportion of 10-year survival due to the presence of nonfull trisomy status (population attributable fraction) was 41.7% for children with T13 and 27.9% for children with T18.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250845-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>The findings of this cohort study of infants with T13 and T18 support differences in long-term survival based on cytogenetic status and emphasize the need to potentially reassess the context of these conditions generally being considered incompatible with life, particularly for those with mosaic trisomies. These findings offer context surrounding treatment decisions, such as withholding interventions, for affected infants in the future.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.29885","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:00:35Z","timestamp":1757343635000},"page":"e2529885","source":"Crossref","is-referenced-by-count":7,"title":["Long-Term Survival Among Children With Trisomy 13 and Trisomy 18 by Cytogenetic Status"],"prefix":"10.1001","volume":"8","author":[{"given":"Katherine L.","family":"Ludorf","sequence":"first","affiliation":[{"name":"Department of Epidemiology, University of Texas Health Science Center at Houston School of Public Health, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata H.","family":"Benjamin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Texas Health Science Center at Houston School of Public Health, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Shumate","sequence":"additional","affiliation":[{"name":"Birth Defects Epidemiology and Surveillance Branch, Texas Department of State Health Services, Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Canfield","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Texas Health Science Center at Houston School of Public Health, Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Birth Defects Epidemiology and Surveillance Branch, Texas Department of State Health Services, Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J.","family":"Agopian","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Texas Health Science Center at Houston School of Public Health, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"issue":"12","key":"zoi250845r1","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1002\/ajmg.a.61365","article-title":"Trisomy 13 and 18-prevalence and mortality: a multi-registry population based analysis.","volume":"179","author":"Goel","year":"2019","journal-title":"Am J Med Genet A"},{"issue":"12","key":"zoi250845r2","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1002\/ajmg.a.37355","article-title":"Congenital anomalies associated with trisomy 18 or trisomy 13: a registry-based study in 16 European countries, 2000-2011.","volume":"167A","author":"Springett","year":"2015","journal-title":"Am J Med Genet A"},{"issue":"1","key":"zoi250845r3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1590\/S0103-05822013000100018","article-title":"Trisomy 18: review of the clinical, etiologic, prognostic, and ethical aspects.","volume":"31","author":"Rosa","year":"2013","journal-title":"Rev Paul Pediatr"},{"issue":"6","key":"zoi250845r4","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1002\/ajmg.a.62175","article-title":"Patterns of congenital anomalies among individuals with trisomy 13 in Texas.","volume":"185","author":"Diaz","year":"2021","journal-title":"Am J Med Genet A"},{"issue":"6","key":"zoi250845r5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1136\/archdischild-2022-325068","article-title":"Ten-year survival of children with trisomy 13 or trisomy 18: a multi-registry European cohort study.","volume":"108","author":"Glinianaia","year":"2023","journal-title":"Arch Dis Child"},{"issue":"8","key":"zoi250845r6","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1001\/jamapediatrics.2024.0885","article-title":"Infant deaths after Texas\u2019 2021 ban on abortion in early pregnancy.","volume":"178","author":"Gemmill","year":"2024","journal-title":"JAMA Pediatr"},{"issue":"5","key":"zoi250845r7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/MOP.0000000000001278","article-title":"The common trisomy syndromes, their cardiac implications, and ethical considerations in care.","volume":"35","author":"Kosiv","year":"2023","journal-title":"Curr Opin Pediatr"},{"issue":"5","key":"zoi250845r8","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.jtcvs.2023.11.054","article-title":"The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: recommendation for the care of children with trisomy 13 or trisomy 18 and a congenital heart defect.","volume":"167","author":"St Louis","year":"2024","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"zoi250845r9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/hmg\/7.4.661","article-title":"Non-disjunction of chromosome 18.","volume":"7","author":"Bugge","year":"1998","journal-title":"Hum Mol Genet"},{"issue":"5","key":"zoi250845r10","doi-asserted-by":"publisher","first-page":"246","DOI":"10.24875\/BMHIM.19000003","article-title":"Trisomy 13 mosaicism.","volume":"76","author":"Cammarata-Scalisi","year":"2019","journal-title":"Boletin Med Hosp Infant Mexico"},{"issue":"10","key":"zoi250845r11","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1002\/ajmg.a.36127","article-title":"Survival of trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome) in England and Wales: 2004-2011.","volume":"161A","author":"Wu","year":"2013","journal-title":"Am J Med Genet A"},{"issue":"4","key":"zoi250845r12","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/ajmg.a.37495","article-title":"Survival of children with trisomy 13 and trisomy 18: a multi-state population-based study.","volume":"170A","author":"Meyer","year":"2016","journal-title":"Am J Med Genet A"},{"issue":"12","key":"zoi250845r13","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/bdra.22858","article-title":"Twenty-five-year survival of children with birth defects in New York State: a population-based study.","volume":"91","author":"Wang","year":"2011","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"8","key":"zoi250845r15","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med"},{"issue":"3","key":"zoi250845r16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/bdra.10012","article-title":"Guidelines for case classification for the National Birth Defects Prevention Study.","volume":"67","author":"Rasmussen","year":"2003","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"1","key":"zoi250845r17","first-page":"4","article-title":"The utility of the National Death Index as a supplemental data source in ascertaining 5-year mortality among Texas heterotaxy cases.","volume":"41","author":"Marengo","year":"2014","journal-title":"J Registry Manag"},{"issue":"19","key":"zoi250845r18","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1002\/bdr2.1608","article-title":"Mortality by mode of delivery among infants with spina bifida in Texas.","volume":"111","author":"Benjamin","year":"2019","journal-title":"Birth Defects Res"},{"issue":"2","key":"zoi250845r19","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1542\/peds.2009-1397","article-title":"Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP.","volume":"124","author":"Mahle","year":"2009","journal-title":"Pediatrics"},{"issue":"3","key":"zoi250845r20","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-0302","article-title":"Sociodemographic factors and survival of infants with congenital heart defects.","volume":"142","author":"Pace","year":"2018","journal-title":"Pediatrics"},{"issue":"5","key":"zoi250845r21","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1097\/EDE.0000000000000864","article-title":"Website and R package for computing E-values.","volume":"29","author":"Mathur","year":"2018","journal-title":"Epidemiology"},{"issue":"3","key":"zoi250845r22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10730-017-9319-2","article-title":"Treatment decisions for babies with trisomy 13 and 18.","volume":"29","author":"Pallotto","year":"2017","journal-title":"HEC Forum"},{"issue":"2","key":"zoi250845r23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1542\/peds.2012-0151","article-title":"The experience of families with children with trisomy 13 and 18 in social networks.","volume":"130","author":"Janvier","year":"2012","journal-title":"Pediatrics"},{"issue":"4","key":"zoi250845r24","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jama.2016.9819","article-title":"Survival and surgical interventions for children with trisomy 13 and 18.","volume":"316","author":"Nelson","year":"2016","journal-title":"JAMA"},{"issue":"6","key":"zoi250845r25","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/ajmg.a.32883","article-title":"Phenotypic variability in trisomy 13 mosaicism: two new patients and literature review.","volume":"149A","author":"Griffith","year":"2009","journal-title":"Am J Med Genet A"},{"issue":"6","key":"zoi250845r26","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41374-019-0230-0","article-title":"Autonomous trisomic rescue of Down syndrome cells.","volume":"99","author":"Inoue","year":"2019","journal-title":"Lab Invest"},{"issue":"1","key":"zoi250845r27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/ajmg.a.36861","article-title":"Mosaicism for trisomy 21: a review.","volume":"167A","author":"Papavassiliou","year":"2015","journal-title":"Am J Med Genet A"},{"issue":"4","key":"zoi250845r28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/ajmg.a.32729","article-title":"The phenotype of persons having mosaicism for trisomy 21\/Down syndrome reflects the percentage of trisomic cells present in different tissues.","volume":"149A","author":"Papavassiliou","year":"2009","journal-title":"Am J Med Genet A"},{"issue":"1","key":"zoi250845r29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0022-3476(05)82547-8","article-title":"Tissue-specific mosaicism for trisomy 21 and congenital heart disease.","volume":"121","author":"Yokoyama","year":"1992","journal-title":"J Pediatr"},{"key":"zoi250845r14","unstructured":"Texas Health and Human Services. Texas Administrative Code. Texas Health and Human Safety Code. Title 25, Part 1, Chapter 37, Subchapter P, Rules 37.301-37.306. Accessed July 30, 2025. https:\/\/texas-sos.appianportalsgov.com\/rules-and-meetings?chapter=37&interface=VIEW_TAC&part=1&subchapter=P&title=25"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2838606\/ludorf_2025_oi_250845_1756497064.73074.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:00:37Z","timestamp":1757343637000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2838606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.29885","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]}}}